HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Papers In Press, published online ahead of print January 1, 2010
J. Lipid Res., doi:10.1194/jlr.M900002-JLR200

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M900002-JLR200v1 51/1/74    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Baranowski, M. Articles by Gorski, J. Search for Related Content PubMed PubMed Citation Articles by Baranowski, M. Articles by Gorski, J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 51, 74-80, January 2010
Copyright © 2010 by American Society for Biochemistry and Molecular Biology

Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide^[S]

Marcin Baranowski^1,*, Agnieszka Blachnio-Zabielska^*, Tomasz Hirnle, Dorota Harasiuk^*, Krzysztof Matlak, Malgorzata Knapp, Piotr Zabielski^* and Jan Gorski^*

^* Departments of Physiology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland
Departments of Cardiac Surgery, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland
Departments of Cardiology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland

¹ To whom correspondence should be addressed. e-mail: marcinb{at}umwb.edu.pl

Data from animal experiments strongly suggest that ceramide is an important mediator of lipotoxicity in the heart and that accumulation of ceramide contributes to cardiomyocyte apoptosis associated with type 2 diabetes and obesity. However, it remains unknown whether a similar relationship is present also in the human heart. Therefore, we aimed to examine whether myocardial apoptosis in obese and type 2 diabetic patients is associated with elevated ceramide level. The study included 11 lean and 26 overweight or moderately obese subjects without (n = 11, OWT) or with (n = 15, T2D-OWT) a history of type 2 diabetes. Samples of the right atrial appendage were obtained from patients at the time of coronary bypass surgery. Compared with lean subjects, the extent of DNA fragmentation (a marker of apoptosis) was significantly higher in the myocardium of OWT patients and increased further in T2D-OWT subjects. However, the content of ceramide and sphingoid bases remained stable. Interestingly, the mRNA level of enzymes involved in synthesis and degradation of ceramide including serine palmitoyltransferase, sphingosine kinase 1, neutral sphingomyelinase, and ceramidases was markedly higher in the myocardium of OWT and T2D-OWT patients compared with lean subjects. Our results indicate that in the human heart, or at least in the atrium, ceramide is not a major factor in cardiomyocyte apoptosis associated with obesity and type 2 diabetes.

Supplementary key words atrium • diabetes • heart • human • obesity • papillary muscle • sphingolipids

Abbreviations: ACO1, acyl-CoA oxidase 1; al/n-Cdase, alkaline/neutral ceramidase; a-CDase, acid ceramidase; a-SMase, acid sphingomyelinase; BMI, body mass index; CPT1-M/L, carnityne palmitoyltransferase 1 muscle/liver isoform; FAT/CD36, fatty acid translocase/CD36; n-Smase, neutral sphingomyelinase; OWT, overweight or moderately obese subjects without a history of type 2 diabetes; PDK4, pyruvate dehydrogenase kinase 4; S1P, sphingosine-1-phosphate; SPHK, sphingosine kinase; SPT, serine palmitoyltransferase; T2D-OWT, overweight or moderately obese subjects with a history of type 2 diabetes; ZDF, Zucker diabetic fatty

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?